Asston Pharmaceuticals Secures International Supply Order Worth INR 2.65 Crore
Asston Pharmaceuticals has received an order from a leading international pharmaceutical company to supply a range of pharma products worth INR 2.65 crore
Pharmaceutical Company | 02/09/2025 | By Dineshwori
Samsung Bioepis Partners with Harrow for US Commercialisation of Ophthalmology Biosimilars
Following the transition of commercial rights from Biogen back to Samsung Bioepis, Harrow will assume full responsibility for the commercialisation of both BYOOVIZ and OPUVIZ biosimilars in the US.
Pharmaceutical Company | 18/07/2025 | By Dineshwori
Samsung Bioepis Partners with Harrow for US Commercialisation of Ophthalmology Biosimilars
Following the transition of commercial rights from Biogen back to Samsung Bioepis, Harrow will assume full responsibility for the commercialisation of both BYOOVIZ and OPUVIZ biosimilars in the US.
Pharmaceutical Company | 18/07/2025 | By Dineshwori
Eton Pharmaceuticals Announces Acquisition of Galzin
Galzin is FDA-approved as a maintenance treatment of patients with Wilson Disease who have been initially treated with a chelating agent.
Pharmaceutical Company | 04/01/2025 | By Aishwarya | 190
Lupin Gains Approval from FDA for Valbenazine Capsules
Lupin Ltd. has received approval from the US FDA for its Abbreviated New Drug Application (ANDA) for Valbenazine Capsules.
Pharmaceutical Company | 09/04/2024 | By Aishwarya | 655
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy